VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.04 | -0.05 | 0.00 |
| FCF Yield | -14.73% | -54.55% | -8.96% | -3.77% |
| EV / EBITDA | -2.15 | -0.35 | -6.73 | -17.07 |
| Quality | ||||
| ROIC | -35.32% | -72.58% | -159.45% | -77.86% |
| Gross Margin | 100.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.60 | 0.83 | 0.64 | 0.63 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 21.97% | -88.48% | -156.17% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 2.64 | 1.19 | 0.70 | -0.01 |
| Interest Coverage | -25.45 | -2,408.78 | -103.36 | -486.30 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 19.09 | 0.00 | 0.00 | 0.00 |